Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Tadmor

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|July 24, 2019
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivorsEstherina Trachtenberg, Ronit Gurion, Tatiana Mashiach, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 13, 2012
Wilms' tumor gene 1: a possible new proangiogenic factor in Hodgkin lymphomaZahava Vadasz, Hadas Shasha-Lavsky, Yuval Nov, et al.
Acta Haematologica|July 30, 2023
Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary SyndromeIlana Levy Yurkovski, Lior Rokach, Guy Melamed, et al.
Cancer|June 23, 2015
Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survivalOsnat Bairey, Lev Shvidel, Chava Perry, et al.
Leukemia Research|November 10, 2020
Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myelomaHadas Rabani, Mira Ziv, Noa Lavi, et al.
Cancer Medicine|October 25, 2023
Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort studyOdit Gutwein, Katrin Herzog Tzarfati, Arie Apel, et al.
British Journal of Haematology|July 6, 2018
Cognitive impairment in hodgkin lymphoma survivorsEstherina Trachtenberg, Tatiana Mashiach, Rachel Ben Hayun, et al.
Leukemia & Lymphoma|March 22, 2026
Complementary and integrative medicine therapy in a hematology division: a retrospective studyIlana Levy Yurkovski, Samuel Attias, Elad Schiff, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2012
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretionYu Zhang, Yair Eliav, Seung-Uon Shin, et al.
Anticancer Research|May 13, 2015
Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemiaLev Shvidel, Osnat Bairey, Tamar Tadmor, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|July 24, 2019
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivorsEstherina Trachtenberg, Ronit Gurion, Tatiana Mashiach, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 13, 2012
Wilms' tumor gene 1: a possible new proangiogenic factor in Hodgkin lymphomaZahava Vadasz, Hadas Shasha-Lavsky, Yuval Nov, et al.
Acta Haematologica|July 30, 2023
Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary SyndromeIlana Levy Yurkovski, Lior Rokach, Guy Melamed, et al.
Cancer|June 23, 2015
Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survivalOsnat Bairey, Lev Shvidel, Chava Perry, et al.
Leukemia Research|November 10, 2020
Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myelomaHadas Rabani, Mira Ziv, Noa Lavi, et al.
Cancer Medicine|October 25, 2023
Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort studyOdit Gutwein, Katrin Herzog Tzarfati, Arie Apel, et al.
British Journal of Haematology|July 6, 2018
Cognitive impairment in hodgkin lymphoma survivorsEstherina Trachtenberg, Tatiana Mashiach, Rachel Ben Hayun, et al.
Leukemia & Lymphoma|March 22, 2026
Complementary and integrative medicine therapy in a hematology division: a retrospective studyIlana Levy Yurkovski, Samuel Attias, Elad Schiff, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2012
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretionYu Zhang, Yair Eliav, Seung-Uon Shin, et al.
Anticancer Research|May 13, 2015
Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemiaLev Shvidel, Osnat Bairey, Tamar Tadmor, et al.
Pageof 15